DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Dermata Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.86−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $3.46M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Dermata Therapeutics has not reported a dividend
No dividend per share appears in Dermata Therapeutics's annual filings since fiscal 2019.